I'm Stevie McLane, a UX designer and creative director in Denton, Texas.
About
I'm working toward a BFA in UX Design at the University of North Texas, class of 2029. The problems I care about most belong to the people a standard product flow quietly leaves out: a patient whose anxiety peaks in the hour before an appointment, or an artist whose releases change style every few weeks and still need to read as one body of work.
I start with research and paper. Interviews, personas and journey maps show me where things break, sketches let me test answers quickly, and Figma is where the decisions get finished. I also write code, so I can carry a design through to a working product and test it on real devices.
Experience
-
Founder and product designer, Any Day Now
CurrentA free package tracker for web, iOS and Android that turns any carrier's updates into a plain-language status, an honest delivery estimate and proactive alerts, in 45 languages. I designed the product end to end, including widgets and Live Activities, and ran accessibility, usability and heuristic audits across 48 page states until it reached zero WCAG 2.2 AA violations.
-
UX designer and researcher, FlexiDoc
Spring 2026Appointment scheduling for patients with agoraphobia, from concept to high-fidelity prototype. Three prototypes, peer usability testing with five users, and revisions that favor low-friction, low-stimulation interactions.
-
Creative director, brand and cover art designer, SLD
2025 to presentA complete brand identity for a musical artist: the logo, a style guide and original cover art for each single, kept consistent across a growing catalog.
Skills
Design and prototyping
Figma, Sketch, Adobe Photoshop, Illustrator and InDesign (Adobe certified in all three)
UX methods
User interviews, usability testing, surveys, design thinking, personas, journey maps, contextual research
Development
HTML, CSS, Java, JSON, Claude Code
Collaboration
Design workshops, peer reviews, constructive critique
Education
BFA in UX Design, University of North Texas
Expected 2029